Katharina Schmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katharina Schmidt has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Kathrin Damm
Center for Health Economics Research Hannover (CHERH), Leibniz University Hannover, Hannover, Germany
3 shared publications - Ana Babac
AOK Bavaria, Munich, Germany
1 shared publication Ari Bryen
Department of History, Western Michigan University, 4301 Friedmann Hall, Kalamazoo, MI 49008-5334, USA
1 shared publicationAriela Gross
Florida State University College of Law
1 shared publication- Arndt Vogel
Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Canada
1 shared publication Barbara Young Welke
Yale University
1 shared publication
Latest Publications
- Open Access
- 1 May 2022
- Published by Cambridge University Press (CUP) in Law and History Review
- Vol. 40 (2) , b1-b4
LHR volume 40 issue 2 Cover and Back matter
- 1 May 2022
- Published by Cambridge University Press (CUP) in Law and History Review
- Vol. 40 (2) , b1-b4
Open AccessLHR volume 40 issue 2 Cover and Back matter
- Open Access
- 1 February 2018
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 11, 7-21
Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study
Objective: The aim of this study was to identify the preferences for whole genome sequencing (WGS) tests without genetic counseling. Methods: A discrete choice experiment was conducted where participants chose between two hypothetical alternatives consisting of the following attributes: test accuracy, test costs, identified diseases, probability of disease occurrence, and data access. People from the general German population aged ≥18 years were eligible to participate in the survey. We estimated generalized linear mixed effects models, latent class mixed-logit models, and the marginal willingness to pay. Results: Three hundred and one participants were included in the final analysis. Overall, the most favored WGS testing attributes were 95% test accuracy, report of severe hereditary diseases and 40% probability of disease development, test costs of €1,000, and access to test results for researchers. Subgroup analysis, however, showed differences in these preferences between males and females. For example, males preferred reporting of results at a 10% probability of disease development and females preferred reporting of results at a 40% probability. The test cost, participant’s educational level, and access to data influenced the willingness to participate in WGS testing in reality. Conclusion: The German general population was aware of the importance of genetic research and preferred to provide their own genetic data for researchers. However, among others, the reporting of results with a comparatively relatively low probability of disease development at a level of 40%, and the test accuracy of 95% had a high preference. This shows that the results and consequences of WGS testing without genetic counseling are hard to assess for individuals. Therefore, WGS testing should be supported by qualified genetic counseling, where the attributes and consequences are explained.
- 1 February 2018
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 11, 7-21
Open AccessWhich attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study
Objective: The aim of this study was to identify the preferences for whole genome sequencing (WGS) tests without genetic counseling. Methods: A discrete choice experiment was conducted where participants chose between two hypothetical alternatives consisting of the following attributes: test accuracy, test costs, identified diseases, probability of disease occurrence, and data access. People from the general German population aged ≥18 years were eligible to participate in the survey. We estimated generalized linear mixed effects models, latent class mixed-logit models, and the marginal willingness to pay. Results: Three hundred and one participants were included in the final analysis. Overall, the most favored WGS testing attributes were 95% test accuracy, report of severe hereditary diseases and 40% probability of disease development, test costs of €1,000, and access to test results for researchers. Subgroup analysis, however, showed differences in these preferences between males and females. For example, males preferred reporting of results at a 10% probability of disease development and females preferred reporting of results at a 40% probability. The test cost, participant’s educational level, and access to data influenced the willingness to participate in WGS testing in reality. Conclusion: The German general population was aware of the importance of genetic research and preferred to provide their own genetic data for researchers. However, among others, the reporting of results with a comparatively relatively low probability of disease development at a level of 40%, and the test accuracy of 95% had a high preference. This shows that the results and consequences of WGS testing without genetic counseling are hard to assess for individuals. Therefore, WGS testing should be supported by qualified genetic counseling, where the attributes and consequences are explained.
- Open Access
- 20 November 2017
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 6 (2) , e23
Shaping an Effective Health Information Website on Rare Diseases Using a Group Decision-Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians
Interactive Journal of Medical Research
- 20 November 2017
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 6 (2) , e23
Open AccessShaping an Effective Health Information Website on Rare Diseases Using a Group Decision-Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians
Interactive Journal of Medical Research
- Open Access
- 1 September 2017
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 11, 1647-1656
Therapy preferences of patients with lung and colon cancer: a discrete choice experiment
Objectives: There is increasing interest in studies that examine patient preferences to measure health-related outcomes. Understanding patients’ preferences can improve the treatment process and is particularly relevant for oncology. In this study, we aimed to identify the subgroup-specific treatment preferences of German patients with lung cancer (LC) or colorectal cancer (CRC). Methods: Six discrete choice experiment (DCE) attributes were established on the basis of a systematic literature review and qualitative interviews. The DCE analyses comprised generalized linear mixed-effects model and latent class mixed logit model. Results: The study cohort comprised 310 patients (194 with LC, 108 with CRC, 8 with both types of cancer) with a median age of 63 (SD =10.66) years. The generalized linear mixed-effects model showed a significant (P Conclusion: Overall survival was the most important attribute of therapy for patients with LC or CRC. Differences in treatment preferences between subgroups should be considered in regard to treatment and development of guidelines. Patients’ preferences were not affected by sex or age, but were affected by the cancer type, HRQoL, surgery status, and the main source of information on the disease.
- 1 September 2017
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 11, 1647-1656
Open AccessTherapy preferences of patients with lung and colon cancer: a discrete choice experiment
Objectives: There is increasing interest in studies that examine patient preferences to measure health-related outcomes. Understanding patients’ preferences can improve the treatment process and is particularly relevant for oncology. In this study, we aimed to identify the subgroup-specific treatment preferences of German patients with lung cancer (LC) or colorectal cancer (CRC). Methods: Six discrete choice experiment (DCE) attributes were established on the basis of a systematic literature review and qualitative interviews. The DCE analyses comprised generalized linear mixed-effects model and latent class mixed logit model. Results: The study cohort comprised 310 patients (194 with LC, 108 with CRC, 8 with both types of cancer) with a median age of 63 (SD =10.66) years. The generalized linear mixed-effects model showed a significant (P Conclusion: Overall survival was the most important attribute of therapy for patients with LC or CRC. Differences in treatment preferences between subgroups should be considered in regard to treatment and development of guidelines. Patients’ preferences were not affected by sex or age, but were affected by the cancer type, HRQoL, surgery status, and the main source of information on the disease.
- 16 September 2016
- Published by Morressier GmbH
Zugang zu Krebssportgruppen - Informationswege und subjektive Einflussgrößen
- 16 September 2016
- Published by Morressier GmbH
Zugang zu Krebssportgruppen - Informationswege und subjektive Einflussgrößen